BR0008046A - Uses of a delta sleep inducing peptide or derivatives and biologically fragments thereof and a compound that decreases the activity of delta sleep inducing peptide and method of assessing the anesthetic needs of an individual to be anesthetized - Google Patents

Uses of a delta sleep inducing peptide or derivatives and biologically fragments thereof and a compound that decreases the activity of delta sleep inducing peptide and method of assessing the anesthetic needs of an individual to be anesthetized

Info

Publication number
BR0008046A
BR0008046A BR0008046-2A BR0008046A BR0008046A BR 0008046 A BR0008046 A BR 0008046A BR 0008046 A BR0008046 A BR 0008046A BR 0008046 A BR0008046 A BR 0008046A
Authority
BR
Brazil
Prior art keywords
sleep inducing
inducing peptide
delta sleep
assessing
delta
Prior art date
Application number
BR0008046-2A
Other languages
Portuguese (pt)
Inventor
Christopher John Doug Pomfrett
Michael Alkire
Richard Haier
Jim Fallon
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902469.7A external-priority patent/GB9902469D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Publication of BR0008046A publication Critical patent/BR0008046A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"USOS DE UM PEPTìDEO INDUTOR DE SONO DELTA OU DERIVADOS E FRAGMENTOS BIOLOGICAMENTE DO MESMO E DE UM COMPOSTO QUE DIMINUI A ATIVIDADE DE PEPTìDEO INDUTOR DE SONO DELTA E MéTODO DE AVALIAR AS NECESSIDADES ANESTéSICAS DE UM INDIVìDUO A SER ANESTESIADO". A presente invenção diz respeito a usos de compostos que modulam o peptídeo indutor de sono delta ativo para regular anestesia e a métodos de avaliar as necessidades anestésicas de um paciente que compreende ensaiar uma amostra coletada do paciente quanto a presença do peptídeo indutor de sono delta."USES OF A DELTA SLEEPING INDUCTIVE PEPTIDE OR DERIVATIVES AND BIOLOGICALLY FRAGMENTS OF THE SAME AND OF A COMPOUND THAT REDUCES THE ACTIVITY OF DELTA SLEEPING INDUCTIVE PEPTIDE AND METHOD OF ASSESSING THE ANESTHETIC NEEDS OF AN INDIVIDUAL TO BE ANESTHETIC TO BE ANESTHETIC. The present invention relates to uses of compounds that modulate the active delta sleep inducing peptide to regulate anesthesia and to methods of assessing the anesthetic needs of a patient comprising testing a sample collected from the patient for the presence of the delta sleep inducing peptide.

BR0008046-2A 1999-02-05 2000-02-01 Uses of a delta sleep inducing peptide or derivatives and biologically fragments thereof and a compound that decreases the activity of delta sleep inducing peptide and method of assessing the anesthetic needs of an individual to be anesthetized BR0008046A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9902469.7A GB9902469D0 (en) 1999-02-05 1999-02-05 Brain metabolism
US12032699P 1999-02-17 1999-02-17
US15566199P 1999-09-24 1999-09-24
PCT/GB2000/000281 WO2000045832A2 (en) 1999-02-05 2000-02-01 Regulation of anaesthesia

Publications (1)

Publication Number Publication Date
BR0008046A true BR0008046A (en) 2001-11-06

Family

ID=27269636

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008046-2A BR0008046A (en) 1999-02-05 2000-02-01 Uses of a delta sleep inducing peptide or derivatives and biologically fragments thereof and a compound that decreases the activity of delta sleep inducing peptide and method of assessing the anesthetic needs of an individual to be anesthetized

Country Status (15)

Country Link
EP (1) EP1148887A2 (en)
JP (1) JP2002536337A (en)
KR (1) KR20010101992A (en)
CN (1) CN1346278A (en)
AP (1) AP2001002245A0 (en)
AU (1) AU2445900A (en)
BR (1) BR0008046A (en)
CA (1) CA2360124A1 (en)
ID (1) ID30518A (en)
IL (1) IL144572A0 (en)
MX (1) MXPA01007949A (en)
NO (1) NO20013795L (en)
OA (1) OA11758A (en)
TR (1) TR200102265T2 (en)
WO (1) WO2000045832A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
EP2205266A2 (en) * 2007-09-11 2010-07-14 Mondobiotech Laboratories AG Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
CN108376559B (en) * 2018-02-28 2020-10-16 复旦大学附属中山医院 Application of acetaldehyde dehydrogenase 2 genotype in calculation of anesthetic dose
CN112535727A (en) * 2020-12-24 2021-03-23 安域生物制药(杭州)有限公司 Short peptide gel with sleep improvement effect and preparation method thereof
CN112908454B (en) * 2021-02-26 2023-08-29 西安交通大学口腔医院 Method and system for intelligently keeping anesthetic

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (en) * 1977-06-30 1983-01-31 Hoffmann La Roche PHOSPHORYLATED NONAPEPTIDES AND METHOD FOR THE PRODUCTION THEREOF.
CA1188989A (en) * 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide for the treatment of drug withdrawal symptoms
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE
RU2104717C1 (en) * 1995-07-07 1998-02-20 Новокузнецкий государственный институт усовершенствования врачей Method of applying anesthesia when operating on patients with leriche's syndrome

Also Published As

Publication number Publication date
WO2000045832A2 (en) 2000-08-10
NO20013795D0 (en) 2001-08-02
JP2002536337A (en) 2002-10-29
MXPA01007949A (en) 2003-06-04
ID30518A (en) 2001-12-13
TR200102265T2 (en) 2001-12-21
NO20013795L (en) 2001-08-02
AU2445900A (en) 2000-08-25
AP2001002245A0 (en) 2001-09-30
CA2360124A1 (en) 2000-08-10
OA11758A (en) 2005-07-19
WO2000045832A3 (en) 2000-11-30
CN1346278A (en) 2002-04-24
KR20010101992A (en) 2001-11-15
EP1148887A2 (en) 2001-10-31
IL144572A0 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
BR0013366A (en) Methods to treat a behavioral disorder, a human patient, prostate disease, anxiety and cognitive disorders in a human patient afflicted with a condition or willing to develop a condition distinguished at least in part by the concentration of abnormal extracellular glutamate in the brain or in other nervous tissue, behavioral disorder in human, canine, feline and equine species and a patient afflicted with or willing to develop a disease comprising abnormally high glutamate concentrations in neuronal tissue or elevated naaladase levels in prostate tissue and with multiple sclerosis and to enhance cognitive function, pharmaceutical formulation and uses of an inhibitor of peptidase activity of an acidic dipeptidase bound in n-acetylated alpha and a beta-lactam compound
ATE344023T1 (en) TRANSDERMAL THERAPEUTIC PATCH WITH CAPSAICIN AND ITS ANALOGUES
DE60043318D1 (en) Synergistic combination of pumafentrine and salmeterol
ATE219674T1 (en) COMPOSITION CONTAINING CAPSAICIN OR ITS ANALOGUES AND LOCAL AESTHETICS
ATE324110T1 (en) SUBSTANCES WITH SEROTONIN-LIKE EFFECTS FOR THE TREATMENT OF SLEEP APNEA
ATE142877T1 (en) MELATONINE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS AND FOR PRE-ANESTHESIA
BR0011823A (en) Benzimidazole derivative, compound, pharmaceutical composition, use of a benzimidazole derivative, and, method for treating, preventing or relieving a disease or disorder or condition of a living animal body
BR0111980A (en) Substituted amine, protected compound, methods for treating a patient having or preventing a patient from contracting a disease or condition, inhibiting beta-secretase activity, inhibiting cleavage of amyloid precursor protein (app), inhibiting Production of the beta amyloid peptide (a beta) in a cell, to inhibit beta0amyloid plaque production in an animal, and to treat or prevent a disease comprising beta-amyloid deposits in the brain, composition method for producing a beta-secretase complex , assembly, and use of substituted amine
DE59508360D1 (en) LIPOSOMAL-ENCLOSED TAXOL, ITS PRODUCTION AND USE
DE60118019D1 (en) COMPOSITION CONTAINING HYDROXYZITRIC ACID AND GARCINOL FOR WEIGHT REDUCTION
BR0317888A (en) Human Growth Hormone Crystals and Processes for Preparing Them
ATE406882T1 (en) COMPOSITIONS FOR NORMALIZING THE CIRCADIAN RYTHM
ATE302025T1 (en) DEVICES FOR THE TREATMENT AND DIAGNOSIS OF RESTLESS LEG SYNDROME
BR0008046A (en) Uses of a delta sleep inducing peptide or derivatives and biologically fragments thereof and a compound that decreases the activity of delta sleep inducing peptide and method of assessing the anesthetic needs of an individual to be anesthetized
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
BR0317519A (en) Pharmaceutical composition for local anesthesia and its use
BRPI0514380A (en) 3-substituted 5- and 6-amnoalkyl indole-2-carboxylic acid amides and related analogues as casein kinase inhibitors
Krueger et al. Somnogenic muramyl peptides
ATE322906T1 (en) USE OF LONG-TERM PENTRAXIN PTX3 FOR THE TREATMENT OF DISEASES CAUSED BY ALTERED ACTIVITY OF THE FGF-2 GROWTH FACTOR
Chavko et al. Extension of brain tolerance to hyperbaric O2 by intermittent air breaks is related to the time of CBF increase
DE602004023861D1 (en) USE OF OXCARBAZEPINE FOR IMPROVING SLEEPING IN PATIENTS SUFFERING CHRONIC PAIN
ATE409469T1 (en) USE OF 2,2,3,3, TETRAMETHYLCYCLOPROPANE CARBOXIC ACID DERIVATIVES FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
HUP9701284A2 (en) Use of 2,3-benzodiazepine derivatives for producing pharmaceutical compositions for treating and prophylacting illnesses and conditions connected with the endogene opioide system
DE69807586D1 (en) Use of an alkylenedioxybenzene derivative for the treatment of circadian sleep disorders
EA200100861A1 (en) REGULATION OF ANESTHESIA

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]